Plasticizer, Di(2-ethylhexyl)phthalate (DEHP), exposure in neonatal ECMO vs. near-miss ECMO patients

Matthew Eig, K. Rais-Bahrami, Steven J. Soldin, Robert McCarter, Damodara R. Mendu, Billie L. Short, Naomi L.C. Luban

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The plastic used in many medical devices is composed primarily of the plastic polyvinyl chloride (PVC). PVC is made flexible by treating it with chemical compounds called plasticizers. The most commonly used plasticizer is di(2-ethylhexyl) phthalate (DEHP). The general population is exposed daily to DEHP and one of its many metabolites, mono(2-ethylhexyl) phthalate (MEHP), primarily through food and aerosolization of environmental exposure. Exposure rises dramatically in premature or ill neonates, who are exposed to medical devices including enteral, blood and infusion bags, tubes and infusion devices. The rate of leaching of DEHP depends on many factors, including contact with lipophilic solutions and the amount of DEHP found in the product. Highly lipophilic substances readily extract plasticizers from PVC bags and tubes. Our objective was to determine the concentration of DEHP and MEHP in the urine of infants undergoing extracorporeal membrane oxygenation (ECMO) and near-miss ECMO to determine if ECMO results in increased concentrations of DEHP and MEHP in the urine. Study design: Using an in vivo prospective comparative study design, we evaluated 12 term or near-term neonates requiring ECMO. Our control population included 17 neonates with similar underlying diagnoses, referred to our NICU for ECMO but who ultimately responded to maximal medical therapy without ECMO. Two baseline urine samples were collected on admission to the NICU for DEHP and MEHP analysis on both the ECMO and near-miss populations. Daily urine samples were collected sequentially for five days in both populations. Urine samples were collected prior to discharge/transfer for both populations. Urinary DEHP and MEHP analysis was performed using tandem mass spectroscopy. Demographic data was collected for each patient. Results: We enrolled a total of twenty-nine patients in the study. All patients were transported to our NICU from outside birthing centers. Twelve neonates required ECMO support. The other seventeen patients responded to maximal medical therapy without ECMO. The mean DEHP for the ECMO group was 38.0 (95% CI=29.6, 47.5) compared to 33.0 (95% CI = 26.6, 40.1) in the near-miss group. The mean MEHP for the ECMO group was 29.8 (95% CI=22.4, 38.2) compared to 26.1 (95% CI=20.6, 32.3) for the near-miss group. Conclusion: Even though urinary levels of DEHP and MEHP were slightly higher in the ECMO group compared to the near-miss group, these differences were not statistically significant.

Original languageEnglish (US)
Pages (from-to)285-291
Number of pages7
JournalJournal of Neonatal-Perinatal Medicine
Volume3
Issue number4
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Plasticizers
Extracorporeal Membrane Oxygenation
Urine
Polyvinyl Chloride
Newborn Infant
Population
Equipment and Supplies
Plastics
phthalic acid
Birthing Centers
Environmental Exposure
mono-(2-ethylhexyl)phthalate
Small Intestine
Mass Spectrometry

Keywords

  • ECOM
  • Neonates
  • placticizers

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Eig, M., Rais-Bahrami, K., Soldin, S. J., McCarter, R., Mendu, D. R., Short, B. L., & Luban, N. L. C. (2010). Plasticizer, Di(2-ethylhexyl)phthalate (DEHP), exposure in neonatal ECMO vs. near-miss ECMO patients. Journal of Neonatal-Perinatal Medicine, 3(4), 285-291. https://doi.org/10.3233/NPM-2010-0127

Plasticizer, Di(2-ethylhexyl)phthalate (DEHP), exposure in neonatal ECMO vs. near-miss ECMO patients. / Eig, Matthew; Rais-Bahrami, K.; Soldin, Steven J.; McCarter, Robert; Mendu, Damodara R.; Short, Billie L.; Luban, Naomi L.C.

In: Journal of Neonatal-Perinatal Medicine, Vol. 3, No. 4, 2010, p. 285-291.

Research output: Contribution to journalArticle

Eig, M, Rais-Bahrami, K, Soldin, SJ, McCarter, R, Mendu, DR, Short, BL & Luban, NLC 2010, 'Plasticizer, Di(2-ethylhexyl)phthalate (DEHP), exposure in neonatal ECMO vs. near-miss ECMO patients', Journal of Neonatal-Perinatal Medicine, vol. 3, no. 4, pp. 285-291. https://doi.org/10.3233/NPM-2010-0127
Eig, Matthew ; Rais-Bahrami, K. ; Soldin, Steven J. ; McCarter, Robert ; Mendu, Damodara R. ; Short, Billie L. ; Luban, Naomi L.C. / Plasticizer, Di(2-ethylhexyl)phthalate (DEHP), exposure in neonatal ECMO vs. near-miss ECMO patients. In: Journal of Neonatal-Perinatal Medicine. 2010 ; Vol. 3, No. 4. pp. 285-291.
@article{af29963fe4424e199005074348fe8a6f,
title = "Plasticizer, Di(2-ethylhexyl)phthalate (DEHP), exposure in neonatal ECMO vs. near-miss ECMO patients",
abstract = "Objective: The plastic used in many medical devices is composed primarily of the plastic polyvinyl chloride (PVC). PVC is made flexible by treating it with chemical compounds called plasticizers. The most commonly used plasticizer is di(2-ethylhexyl) phthalate (DEHP). The general population is exposed daily to DEHP and one of its many metabolites, mono(2-ethylhexyl) phthalate (MEHP), primarily through food and aerosolization of environmental exposure. Exposure rises dramatically in premature or ill neonates, who are exposed to medical devices including enteral, blood and infusion bags, tubes and infusion devices. The rate of leaching of DEHP depends on many factors, including contact with lipophilic solutions and the amount of DEHP found in the product. Highly lipophilic substances readily extract plasticizers from PVC bags and tubes. Our objective was to determine the concentration of DEHP and MEHP in the urine of infants undergoing extracorporeal membrane oxygenation (ECMO) and near-miss ECMO to determine if ECMO results in increased concentrations of DEHP and MEHP in the urine. Study design: Using an in vivo prospective comparative study design, we evaluated 12 term or near-term neonates requiring ECMO. Our control population included 17 neonates with similar underlying diagnoses, referred to our NICU for ECMO but who ultimately responded to maximal medical therapy without ECMO. Two baseline urine samples were collected on admission to the NICU for DEHP and MEHP analysis on both the ECMO and near-miss populations. Daily urine samples were collected sequentially for five days in both populations. Urine samples were collected prior to discharge/transfer for both populations. Urinary DEHP and MEHP analysis was performed using tandem mass spectroscopy. Demographic data was collected for each patient. Results: We enrolled a total of twenty-nine patients in the study. All patients were transported to our NICU from outside birthing centers. Twelve neonates required ECMO support. The other seventeen patients responded to maximal medical therapy without ECMO. The mean DEHP for the ECMO group was 38.0 (95{\%} CI=29.6, 47.5) compared to 33.0 (95{\%} CI = 26.6, 40.1) in the near-miss group. The mean MEHP for the ECMO group was 29.8 (95{\%} CI=22.4, 38.2) compared to 26.1 (95{\%} CI=20.6, 32.3) for the near-miss group. Conclusion: Even though urinary levels of DEHP and MEHP were slightly higher in the ECMO group compared to the near-miss group, these differences were not statistically significant.",
keywords = "ECOM, Neonates, placticizers",
author = "Matthew Eig and K. Rais-Bahrami and Soldin, {Steven J.} and Robert McCarter and Mendu, {Damodara R.} and Short, {Billie L.} and Luban, {Naomi L.C.}",
year = "2010",
doi = "10.3233/NPM-2010-0127",
language = "English (US)",
volume = "3",
pages = "285--291",
journal = "Journal of Neonatal-Perinatal Medicine",
issn = "1934-5798",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Plasticizer, Di(2-ethylhexyl)phthalate (DEHP), exposure in neonatal ECMO vs. near-miss ECMO patients

AU - Eig, Matthew

AU - Rais-Bahrami, K.

AU - Soldin, Steven J.

AU - McCarter, Robert

AU - Mendu, Damodara R.

AU - Short, Billie L.

AU - Luban, Naomi L.C.

PY - 2010

Y1 - 2010

N2 - Objective: The plastic used in many medical devices is composed primarily of the plastic polyvinyl chloride (PVC). PVC is made flexible by treating it with chemical compounds called plasticizers. The most commonly used plasticizer is di(2-ethylhexyl) phthalate (DEHP). The general population is exposed daily to DEHP and one of its many metabolites, mono(2-ethylhexyl) phthalate (MEHP), primarily through food and aerosolization of environmental exposure. Exposure rises dramatically in premature or ill neonates, who are exposed to medical devices including enteral, blood and infusion bags, tubes and infusion devices. The rate of leaching of DEHP depends on many factors, including contact with lipophilic solutions and the amount of DEHP found in the product. Highly lipophilic substances readily extract plasticizers from PVC bags and tubes. Our objective was to determine the concentration of DEHP and MEHP in the urine of infants undergoing extracorporeal membrane oxygenation (ECMO) and near-miss ECMO to determine if ECMO results in increased concentrations of DEHP and MEHP in the urine. Study design: Using an in vivo prospective comparative study design, we evaluated 12 term or near-term neonates requiring ECMO. Our control population included 17 neonates with similar underlying diagnoses, referred to our NICU for ECMO but who ultimately responded to maximal medical therapy without ECMO. Two baseline urine samples were collected on admission to the NICU for DEHP and MEHP analysis on both the ECMO and near-miss populations. Daily urine samples were collected sequentially for five days in both populations. Urine samples were collected prior to discharge/transfer for both populations. Urinary DEHP and MEHP analysis was performed using tandem mass spectroscopy. Demographic data was collected for each patient. Results: We enrolled a total of twenty-nine patients in the study. All patients were transported to our NICU from outside birthing centers. Twelve neonates required ECMO support. The other seventeen patients responded to maximal medical therapy without ECMO. The mean DEHP for the ECMO group was 38.0 (95% CI=29.6, 47.5) compared to 33.0 (95% CI = 26.6, 40.1) in the near-miss group. The mean MEHP for the ECMO group was 29.8 (95% CI=22.4, 38.2) compared to 26.1 (95% CI=20.6, 32.3) for the near-miss group. Conclusion: Even though urinary levels of DEHP and MEHP were slightly higher in the ECMO group compared to the near-miss group, these differences were not statistically significant.

AB - Objective: The plastic used in many medical devices is composed primarily of the plastic polyvinyl chloride (PVC). PVC is made flexible by treating it with chemical compounds called plasticizers. The most commonly used plasticizer is di(2-ethylhexyl) phthalate (DEHP). The general population is exposed daily to DEHP and one of its many metabolites, mono(2-ethylhexyl) phthalate (MEHP), primarily through food and aerosolization of environmental exposure. Exposure rises dramatically in premature or ill neonates, who are exposed to medical devices including enteral, blood and infusion bags, tubes and infusion devices. The rate of leaching of DEHP depends on many factors, including contact with lipophilic solutions and the amount of DEHP found in the product. Highly lipophilic substances readily extract plasticizers from PVC bags and tubes. Our objective was to determine the concentration of DEHP and MEHP in the urine of infants undergoing extracorporeal membrane oxygenation (ECMO) and near-miss ECMO to determine if ECMO results in increased concentrations of DEHP and MEHP in the urine. Study design: Using an in vivo prospective comparative study design, we evaluated 12 term or near-term neonates requiring ECMO. Our control population included 17 neonates with similar underlying diagnoses, referred to our NICU for ECMO but who ultimately responded to maximal medical therapy without ECMO. Two baseline urine samples were collected on admission to the NICU for DEHP and MEHP analysis on both the ECMO and near-miss populations. Daily urine samples were collected sequentially for five days in both populations. Urine samples were collected prior to discharge/transfer for both populations. Urinary DEHP and MEHP analysis was performed using tandem mass spectroscopy. Demographic data was collected for each patient. Results: We enrolled a total of twenty-nine patients in the study. All patients were transported to our NICU from outside birthing centers. Twelve neonates required ECMO support. The other seventeen patients responded to maximal medical therapy without ECMO. The mean DEHP for the ECMO group was 38.0 (95% CI=29.6, 47.5) compared to 33.0 (95% CI = 26.6, 40.1) in the near-miss group. The mean MEHP for the ECMO group was 29.8 (95% CI=22.4, 38.2) compared to 26.1 (95% CI=20.6, 32.3) for the near-miss group. Conclusion: Even though urinary levels of DEHP and MEHP were slightly higher in the ECMO group compared to the near-miss group, these differences were not statistically significant.

KW - ECOM

KW - Neonates

KW - placticizers

UR - http://www.scopus.com/inward/record.url?scp=78650275944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650275944&partnerID=8YFLogxK

U2 - 10.3233/NPM-2010-0127

DO - 10.3233/NPM-2010-0127

M3 - Article

AN - SCOPUS:78650275944

VL - 3

SP - 285

EP - 291

JO - Journal of Neonatal-Perinatal Medicine

JF - Journal of Neonatal-Perinatal Medicine

SN - 1934-5798

IS - 4

ER -